Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autoimmune disorder in which immune cells attack and destroy the glands that produce tears and saliva. Sjögren syndrome is also associated with rheumatic disorders such as rheumatoid arthritis or systemic lupus erythematosus. The hallmark symptoms of Sjögren syndrome are dry mouth and dry eyes. In addition, Sjogren syndrome may cause skin, nose, and vaginal dryness. It also may affect other organs of the body including the kidneys, blood vessels, lungs, liver, pancreas, and brain
Features include very common findings: Keratoconjunctivitis sicca and Xerostomia; and common findings: Elevated erythrocyte sedimentation rate, Tubulointerstitial nephritis, Increased circulating globulin level, and Anti-La/SS-B antibody positivity and others. 91 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 13 | Nervous system problems (abnormality of the nervous system), Anxiety, Fatigue |
Biomarker and diagnostic research for Sjogren syndrome has been reported in the published literature.
Phenotype severity distribution: 2 very common features, 23 common features.
Estimated prevalence: 1-5 in 10,000 (Uncommon).
25 clinical trials registered, 9 recruiting. Interventions under study include drug therapy, other interventions, biologic therapy, and medical devices. Pipeline includes 2 PHASE4, 3 PHASE3, 5 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06991114](https://clinicaltrials.gov/study/NCT06991114) |
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 7:14 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Lab test results | 10 | Anti-La/SS-B antibody positivity, Anti-Ro/SS-A antibody positivity, Elevated CRP (inflammation marker) (elevated circulating c-reactive protein concentration) |
Blood and immune system | 9 | Autoimmunity, Abnormality of blood and blood-forming tissues, Low platelet count (thrombocytopenia) |
Skin | 7 | Skin rash, Abnormality of the skin, Dry skin |
Lungs and breathing | 6 | Usual interstitial pneumonia, Lymphocytic interstitial pneumonia, Abnormal lung tissue (abnormal pulmonary interstitial morphology) |
Kidneys and urinary system | 4 | Tubulointerstitial nephritis, Abnormality of the kidney, Reduced kidney function (renal insufficiency) |
Bones and joints | 3 | Rheumatoid arthritis, Arthralgia, Joint inflammation (arthritis) |
Muscles | 3 | Abnormality of the musculature, Muscle weakness, Myalgia |
Digestive system | 3 | Biliary cirrhosis, Chronic hepatitis, Chronic active hepatitis |
Eyes | 2 | Optic neuritis, Corneal perforation |
Nervous system (morphological) | 1 | Morphological central nervous system abnormality |
Hormones | 1 | Thyroiditis |
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. |
PHASE2 |
Artiva Biotherapeutics, Inc. |
RECRUITING |
[NCT07153276](https://clinicaltrials.gov/study/NCT07153276) | TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE | PHASE4 | University of Sao Paulo General Hospital | RECRUITING |
[NCT06732674](https://clinicaltrials.gov/study/NCT06732674) | Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases | NA | Oslo University Hospital | RECRUITING |
[NCT06794008](https://clinicaltrials.gov/study/NCT06794008) | BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases | PHASE2 | Peking University People's Hospital | RECRUITING |
[NCT03509064](https://clinicaltrials.gov/study/NCT03509064) | Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy | — | Assistance Publique - Hôpitaux de Paris | RECRUITING |
287 publications have been identified in PubMed for Sjogren syndrome. Kisho has analyzed 74 by research type. Research spans Review / Meta-Analysis (45%), Epidemiology / Natural History (27%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 33 | 45% |
Disease patterns and progression | 20 | 27% |
Laboratory research | 12 | 16% |
Patient case studies | 5 | 7% |
Clinical study results | 2 | 3% |
Testing and diagnosis research | 1 | 1% |
New treatment approaches | 1 | 1% |
Baigrie D (2026). [PMID: 29489227](https://pubmed.ncbi.nlm.nih.gov/29489227/). *Unknown Journal*. [Basic Science / Preclinical]
Jaeger ZJ (2026). [PMID: 42016788](https://pubmed.ncbi.nlm.nih.gov/42016788/). *JAAD Case Rep*. [Epidemiology / Natural History]
Margolin E (2026). [PMID: 33232023](https://pubmed.ncbi.nlm.nih.gov/33232023/). *Unknown Journal*. [Epidemiology / Natural History]
Diaz-Frias J (2026). [PMID: 30252317](https://pubmed.ncbi.nlm.nih.gov/30252317/). *Unknown Journal*. [Epidemiology / Natural History]
Moseley CE (2026). [PMID: 41270250](https://pubmed.ncbi.nlm.nih.gov/41270250/). *Neurol Neuroimmunol Neuroinflamm*. [Basic Science / Preclinical]
Burrow MK (2026). [PMID: 31194419](https://pubmed.ncbi.nlm.nih.gov/31194419/). *Unknown Journal*. [Epidemiology / Natural History]
Kılınç AK (2026). [PMID: 41511459](https://pubmed.ncbi.nlm.nih.gov/41511459/). *Ocul Immunol Inflamm*. [Epidemiology / Natural History]
Ono N (2025). [PMID: 40045586](https://pubmed.ncbi.nlm.nih.gov/40045586/). *Mod Rheumatol Case Rep*. [Review / Meta-Analysis]
Hara M (2025). [PMID: 40130134](https://pubmed.ncbi.nlm.nih.gov/40130134/). *Cureus*. [Case Report / Case Series]
Pilato A (2025). [PMID: 40807016](https://pubmed.ncbi.nlm.nih.gov/40807016/). *J Clin Med*. [Review / Meta-Analysis]